KR20180072705A - 소분자 글리코실화 방법 - Google Patents
소분자 글리코실화 방법 Download PDFInfo
- Publication number
- KR20180072705A KR20180072705A KR1020187011643A KR20187011643A KR20180072705A KR 20180072705 A KR20180072705 A KR 20180072705A KR 1020187011643 A KR1020187011643 A KR 1020187011643A KR 20187011643 A KR20187011643 A KR 20187011643A KR 20180072705 A KR20180072705 A KR 20180072705A
- Authority
- KR
- South Korea
- Prior art keywords
- sucrose
- sucrose phosphorylase
- phosphorylase
- ascorbic acid
- glucosyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000000034 method Methods 0.000 title claims abstract description 47
- 230000013595 glycosylation Effects 0.000 title description 6
- 238000006206 glycosylation reaction Methods 0.000 title description 6
- 150000003384 small molecules Chemical class 0.000 title 1
- 108020000005 Sucrose phosphorylase Proteins 0.000 claims abstract description 62
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims abstract description 33
- 230000008569 process Effects 0.000 claims abstract description 12
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 claims abstract description 10
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 36
- 229930006000 Sucrose Natural products 0.000 claims description 36
- 239000005720 sucrose Substances 0.000 claims description 36
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 33
- 239000000386 donor Substances 0.000 claims description 26
- 229960005070 ascorbic acid Drugs 0.000 claims description 23
- 238000006243 chemical reaction Methods 0.000 claims description 21
- 108090000623 proteins and genes Proteins 0.000 claims description 21
- 238000011534 incubation Methods 0.000 claims description 20
- 239000002211 L-ascorbic acid Substances 0.000 claims description 19
- 102000004169 proteins and genes Human genes 0.000 claims description 16
- 241000186000 Bifidobacterium Species 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 10
- 241000588724 Escherichia coli Species 0.000 claims description 8
- 241000194019 Streptococcus mutans Species 0.000 claims description 8
- 239000011541 reaction mixture Substances 0.000 claims description 8
- 241001608472 Bifidobacterium longum Species 0.000 claims description 7
- 239000012634 fragment Substances 0.000 claims description 7
- 230000001580 bacterial effect Effects 0.000 claims description 6
- 229940009291 bifidobacterium longum Drugs 0.000 claims description 6
- 239000000710 homodimer Substances 0.000 claims description 6
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 5
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 5
- 241000589516 Pseudomonas Species 0.000 claims description 5
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 5
- HXXFSFRBOHSIMQ-VFUOTHLCSA-N alpha-D-glucose 1-phosphate Chemical group OC[C@H]1O[C@H](OP(O)(O)=O)[C@H](O)[C@@H](O)[C@@H]1O HXXFSFRBOHSIMQ-VFUOTHLCSA-N 0.000 claims description 4
- 235000010323 ascorbic acid Nutrition 0.000 claims description 4
- 239000011668 ascorbic acid Substances 0.000 claims description 4
- 235000020046 sherry Nutrition 0.000 claims description 4
- 241000186779 Listeria monocytogenes Species 0.000 claims description 3
- 150000001720 carbohydrates Chemical class 0.000 claims description 3
- 108020001507 fusion proteins Proteins 0.000 claims description 3
- 102000037865 fusion proteins Human genes 0.000 claims description 3
- 229950010772 glucose-1-phosphate Drugs 0.000 claims description 3
- 241000589176 Agrobacterium vitis Species 0.000 claims description 2
- 241000186018 Bifidobacterium adolescentis Species 0.000 claims description 2
- 241000328888 Candidatus Solibacter usitatus Species 0.000 claims description 2
- 241000186660 Lactobacillus Species 0.000 claims description 2
- 241000186673 Lactobacillus delbrueckii Species 0.000 claims description 2
- 241000192130 Leuconostoc mesenteroides Species 0.000 claims description 2
- 241000589956 Pirellula Species 0.000 claims description 2
- 241000092274 Rhodopirellula baltica Species 0.000 claims description 2
- 241000878021 Shewanella baltica Species 0.000 claims description 2
- 241000557287 Shewanella frigidimarina Species 0.000 claims description 2
- 241000863432 Shewanella putrefaciens Species 0.000 claims description 2
- 241000192707 Synechococcus Species 0.000 claims description 2
- 239000000348 glycosyl donor Substances 0.000 claims description 2
- 229940039696 lactobacillus Drugs 0.000 claims description 2
- 244000005700 microbiome Species 0.000 claims description 2
- 241001147746 Lactobacillus delbrueckii subsp. lactis Species 0.000 claims 1
- 241000589779 Pelomonas saccharophila Species 0.000 claims 1
- 230000002378 acidificating effect Effects 0.000 abstract description 3
- 239000000370 acceptor Substances 0.000 abstract 1
- 108010019589 Staphylococcus aureus glutamic acid-specific endopeptidase Proteins 0.000 description 40
- 102000004190 Enzymes Human genes 0.000 description 26
- 108090000790 Enzymes Proteins 0.000 description 26
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 26
- 229940088598 enzyme Drugs 0.000 description 26
- 230000000694 effects Effects 0.000 description 25
- 239000000758 substrate Substances 0.000 description 16
- 239000006227 byproduct Substances 0.000 description 14
- 238000004519 manufacturing process Methods 0.000 description 14
- 235000000069 L-ascorbic acid Nutrition 0.000 description 13
- 230000015572 biosynthetic process Effects 0.000 description 13
- 102000051366 Glycosyltransferases Human genes 0.000 description 11
- 108700023372 Glycosyltransferases Proteins 0.000 description 11
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 10
- 102000001708 Protein Isoforms Human genes 0.000 description 10
- 108010029485 Protein Isoforms Proteins 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 8
- 108010025880 Cyclomaltodextrin glucanotransferase Proteins 0.000 description 7
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 7
- 238000003786 synthesis reaction Methods 0.000 description 7
- 229910019142 PO4 Inorganic materials 0.000 description 6
- 239000010452 phosphate Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 108700014210 glycosyltransferase activity proteins Proteins 0.000 description 5
- 108090000765 processed proteins & peptides Proteins 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 102100031126 6-phosphogluconolactonase Human genes 0.000 description 4
- 108010029731 6-phosphogluconolactonase Proteins 0.000 description 4
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 4
- 102100022624 Glucoamylase Human genes 0.000 description 4
- 108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 description 4
- 108010073135 Phosphorylases Proteins 0.000 description 4
- 102000009097 Phosphorylases Human genes 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
- 230000004071 biological effect Effects 0.000 description 4
- 229930182478 glucoside Natural products 0.000 description 4
- 150000008131 glucosides Chemical class 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000012539 chromatography resin Substances 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 229930182470 glycoside Natural products 0.000 description 3
- 150000002338 glycosides Chemical class 0.000 description 3
- 125000003147 glycosyl group Chemical group 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 125000000185 sucrose group Chemical group 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-DVKNGEFBSA-N alpha-D-glucose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-DVKNGEFBSA-N 0.000 description 2
- 108010028144 alpha-Glucosidases Proteins 0.000 description 2
- -1 alpha-glucosyl saccharides Chemical class 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000007979 citrate buffer Substances 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 150000002016 disaccharides Chemical class 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 229910052816 inorganic phosphate Inorganic materials 0.000 description 2
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
- 238000011031 large-scale manufacturing process Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000012038 nucleophile Substances 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000005918 transglycosylation reaction Methods 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- NHJUPBDCSOGIKX-QMWFWAMKSA-N 1-O-(D-glucosyl)glycerol Chemical compound OCC(O)COC1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NHJUPBDCSOGIKX-QMWFWAMKSA-N 0.000 description 1
- 241000589158 Agrobacterium Species 0.000 description 1
- 241000186074 Arthrobacter globiformis Species 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- NBSCHQHZLSJFNQ-GASJEMHNSA-N D-Glucose 6-phosphate Chemical compound OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O NBSCHQHZLSJFNQ-GASJEMHNSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- HXXFSFRBOHSIMQ-GASJEMHNSA-N D-glucopyranose 1-phosphate Chemical compound OC[C@H]1OC(OP(O)(O)=O)[C@H](O)[C@@H](O)[C@@H]1O HXXFSFRBOHSIMQ-GASJEMHNSA-N 0.000 description 1
- HXXFSFRBOHSIMQ-UHFFFAOYSA-N Di-K salt-alpha-D-Pyranose-Galactose 1-dihydrogen phosphate Natural products OCC1OC(OP(O)(O)=O)C(O)C(O)C1O HXXFSFRBOHSIMQ-UHFFFAOYSA-N 0.000 description 1
- 241000672609 Escherichia coli BL21 Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- VFRROHXSMXFLSN-UHFFFAOYSA-N Glc6P Natural products OP(=O)(O)OCC(O)C(O)C(O)C(O)C=O VFRROHXSMXFLSN-UHFFFAOYSA-N 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 150000000996 L-ascorbic acids Chemical class 0.000 description 1
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- RWHOZGRAXYWRNX-VFUOTHLCSA-N alpha-D-glucose 1,6-bisphosphate Chemical compound O[C@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H](OP(O)(O)=O)[C@@H]1O RWHOZGRAXYWRNX-VFUOTHLCSA-N 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000005571 anion exchange chromatography Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 239000011942 biocatalyst Substances 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000005277 cation exchange chromatography Methods 0.000 description 1
- 239000003729 cation exchange resin Substances 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000006392 deoxygenation reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000003370 dye binding method Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000007824 enzymatic assay Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000009585 enzyme analysis Methods 0.000 description 1
- 238000006345 epimerization reaction Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 125000005640 glucopyranosyl group Chemical group 0.000 description 1
- 150000002303 glucose derivatives Chemical class 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000001279 glycosylating effect Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 125000001553 ketosyl group Chemical group 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000008057 potassium phosphate buffer Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 238000012289 standard assay Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- ISIJQEHRDSCQIU-UHFFFAOYSA-N tert-butyl 2,7-diazaspiro[4.5]decane-7-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCCC11CNCC1 ISIJQEHRDSCQIU-UHFFFAOYSA-N 0.000 description 1
- 239000012049 topical pharmaceutical composition Substances 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000006276 transfer reaction Methods 0.000 description 1
- 230000006098 transglycosylation Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000008496 α-D-glucosides Chemical class 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
- C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1051—Hexosyltransferases (2.4.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1051—Hexosyltransferases (2.4.1)
- C12N9/1066—Sucrose phosphate synthase (2.4.1.14)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y204/00—Glycosyltransferases (2.4)
- C12Y204/01—Hexosyltransferases (2.4.1)
- C12Y204/01007—Sucrose phosphorylase (2.4.1.7)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15186888.2 | 2015-09-25 | ||
| EP15186888 | 2015-09-25 | ||
| PCT/EP2016/072586 WO2017050920A1 (en) | 2015-09-25 | 2016-09-22 | Method for small molecule glycosylation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20180072705A true KR20180072705A (ko) | 2018-06-29 |
Family
ID=54251987
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020187011643A Withdrawn KR20180072705A (ko) | 2015-09-25 | 2016-09-22 | 소분자 글리코실화 방법 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20180291410A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3353311B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7000327B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20180072705A (cg-RX-API-DMAC7.html) |
| CN (1) | CN108350474B (cg-RX-API-DMAC7.html) |
| ES (1) | ES2886572T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2017050920A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108913641B (zh) * | 2018-06-29 | 2021-02-02 | 浙江工业大学 | 一种重组大肠杆菌及其应用 |
| CN109988778B (zh) * | 2019-05-14 | 2020-10-27 | 南京工业大学 | 一种蔗糖磷酸化酶基因及其应用 |
| CN111172128A (zh) * | 2020-01-21 | 2020-05-19 | 浙江工业大学 | 一种蔗糖磷酸化酶在制备2-O-α-D-葡萄糖基-L-抗坏血酸中的应用 |
| CN113980932B (zh) * | 2021-07-15 | 2023-08-01 | 暨南大学 | 一种定点突变的α-葡萄糖苷酶 |
| CN115786388B (zh) * | 2022-12-26 | 2025-01-14 | 暨南大学 | 生产2-O-α-D-吡喃葡萄糖基-L-抗坏血酸的基因工程菌及其构建方法与应用 |
| CN116144625A (zh) * | 2023-02-24 | 2023-05-23 | 杭州佳嘉乐生物技术有限公司 | 重组蔗糖磷酸化酶及其催化糖基化反应的方法 |
| CN120230742B (zh) * | 2025-06-03 | 2025-07-29 | 山东三元生物科技股份有限公司 | 一种固定化细胞及其制备方法和2-O-α-D-吡喃葡萄糖基-L-抗坏血酸的制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2832848B2 (ja) | 1989-10-21 | 1998-12-09 | 株式会社林原生物化学研究所 | 結晶２―Ｏ―α―Ｄ―グルコピラノシル―Ｌ―アスコルビン酸とその製造方法並びに用途 |
| JP3134235B2 (ja) | 1991-10-23 | 2001-02-13 | 株式会社林原生物化学研究所 | ２−Ｏ−α−Ｄ−グルコピラノシル−Ｌ−アスコルビン酸高含有物の製造方法 |
| US20020006418A1 (en) * | 1998-10-13 | 2002-01-17 | John Kung | Composition to enhance permeation of topical skin agents |
| JP4043312B2 (ja) | 2002-08-06 | 2008-02-06 | 株式会社林原生物化学研究所 | ２−Ｏ−α−Ｄ−グルコピラノシル−Ｌ−アスコルビン酸の製造方法 |
| JP2014518611A (ja) * | 2011-03-25 | 2014-08-07 | プロテロ インコーポレイテッド | 調節された遺伝子発現系およびその構築物 |
| WO2014060452A1 (en) * | 2012-10-18 | 2014-04-24 | Universiteit Gent | A thermostable sucrose and sucrose-6'-phosphate phosphorylase |
| CN103122341B (zh) * | 2013-01-08 | 2015-05-13 | 江南大学 | 一种麦芽糊精底物特异性提高的环糊精糖基转移酶及其制备方法 |
| CN104531629B (zh) * | 2014-12-16 | 2017-07-21 | 江南大学 | 一种提高aa‑2g转化率的环糊精葡萄糖基转移酶突变体 |
-
2016
- 2016-09-22 WO PCT/EP2016/072586 patent/WO2017050920A1/en not_active Ceased
- 2016-09-22 US US15/762,082 patent/US20180291410A1/en not_active Abandoned
- 2016-09-22 JP JP2018535237A patent/JP7000327B2/ja active Active
- 2016-09-22 EP EP16775588.3A patent/EP3353311B1/en active Active
- 2016-09-22 ES ES16775588T patent/ES2886572T3/es active Active
- 2016-09-22 KR KR1020187011643A patent/KR20180072705A/ko not_active Withdrawn
- 2016-09-22 CN CN201680062080.0A patent/CN108350474B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP7000327B2 (ja) | 2022-02-04 |
| ES2886572T3 (es) | 2021-12-20 |
| CN108350474B (zh) | 2022-06-28 |
| EP3353311A1 (en) | 2018-08-01 |
| EP3353311B1 (en) | 2021-06-16 |
| JP2018535693A (ja) | 2018-12-06 |
| WO2017050920A1 (en) | 2017-03-30 |
| CN108350474A (zh) | 2018-07-31 |
| US20180291410A1 (en) | 2018-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10683525B2 (en) | Method for producing 2-O-glyceryl-alpha-D-glucopyranoside | |
| KR20180072705A (ko) | 소분자 글리코실화 방법 | |
| JP6479084B2 (ja) | 一連の糖転移酵素およびその応用 | |
| JP6165872B2 (ja) | 単糖類の製造方法 | |
| KR20090010024A (ko) | 유전자 조작법에 의한 덱스트란수크라제 ｄｓｒ－ｓ의 신규변이체의 제조 | |
| JP4043015B2 (ja) | 糖転移物の製造方法 | |
| CN113265433B (zh) | 双功能碳苷糖基转移酶及其应用 | |
| WO1995034642A1 (en) | Novel transferase and amylase, process for producing the enzymes,use thereof, and gene coding for the same | |
| CN109415747B (zh) | 一种酶改质甜菊糖的制备方法和制备用酶及应用 | |
| EP2186904B1 (en) | Method for producing glucose derivatives | |
| JP2017123844A (ja) | 配糖体の製造方法 | |
| US5804426A (en) | Recombinant cyclodextran glucanotransferase mutants | |
| KR101978565B1 (ko) | 루미노코커스 브로미 유래 풀루란 분해 효소 및 이의 용도 | |
| DK182217B1 (en) | Enzymatic n-acetyllactosaminylation of a terminal galactose in its 6-position | |
| EP0263955A2 (en) | Process for the production of panosyl derivatives | |
| CN111635894B (zh) | 粉蝶霉素糖基转移酶sGT1及应用 | |
| CN121271818A (zh) | 一种蔗糖磷酸化酶突变体及其应用 | |
| CN117413056A (zh) | 用于果寡糖的优化生产的经修饰的果聚糖蔗糖酶 | |
| KR101655237B1 (ko) | 고정화된 아밀레이즈를 이용한 말토덱스트린의 연속 제조방법 | |
| KR101707928B1 (ko) | CGTase 변이효소를 이용한 고순도 말토헵타오스의 제조방법 | |
| KR20070105563A (ko) | 바실러스 세레우스 균주로부터 유래한 당전이효소, 그의유전자 및 그들의 제조방법 | |
| CN114015735A (zh) | 一种蔗糖磷酸化酶和葡萄糖异构酶级联催化合成黑曲霉二糖的方法 | |
| JP2005210925A (ja) | グルコシル基の転移方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20180424 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| PN2301 | Change of applicant |
Patent event date: 20191023 Comment text: Notification of Change of Applicant Patent event code: PN23011R01D |
|
| PC1203 | Withdrawal of no request for examination |